Effectiveness of Ledipasvir-Sofosbuvir Combination in Patients With Hepatitis C Virus Infection and Factors Associated With Sustained Virologic Response

BACKGROUND & AIMS: The combination of ledipasvir and sofosbuvir has been approved for treatment of genotype 1 hepatitis C virus (HCV) infection, including an 8-week regimen for treatment-naïve patients without cirrhosis and a baseline level of HCV RNA <6 million IU/mL. We analyzed data from a...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Gastroenterology
Auteurs principaux: Terrault, Norah A., Zeuzem, Stefan, Di Bisceglie, Adrian M., Lim, Joseph K., Pockros, Paul J., Frazier, Lynn M., Kuo, Alexander, Lok, Anna S., Shiffman, Mitchell L., Ben Ari, Ziv, Akushevich, Lucy, Vainorius, Monika, Sulkowski, Mark S., Fried, Michael W., Nelson, David R.
Format: Artigo
Langue:Inglês
Publié: 2016
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5300778/
https://ncbi.nlm.nih.gov/pubmed/27565882
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.gastro.2016.08.004
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires